Hide
Show all
Email this article 
Antibacterial Activity of Planchonia valida Against Methicillin-Resistant Staphylococcus aureus (MRSA): Phytochemical Profiling, LC-MS Analysis, and Molecular Docking Study
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major antimicrobial-resistant pathogen, creating a need for alternative antibacterial agents from natural resources. This study aimed to evaluate the antibacterial activity of Planchonia valida leaf extracts against MRSA and investigate potential bioactive constituents associated with the observed activity through phytochemical profiling, LC–MS analysis, and molecular docking. Leaves of P. valida were extracted using n-hexane, ethyl acetate, and methanol, and antibacterial activity was evaluated using the disk diffusion method. The most active extract was further characterized through phytochemical screening and LC–MS analysis, while tentatively annotated metabolites were evaluated by molecular docking against penicillin-binding protein 2a (PBP2a). The ethyl acetate extract exhibited the strongest antibacterial activity, producing an inhibition zone of 14.33 ± 0.32 mm at 30% (w/v). Phytochemical screening indicated the presence of terpenoids, steroids, alkaloids, and flavonoids, with flavonoids showing the strongest qualitative response. LC–MS analysis tentatively annotated five flavonoid-related compounds, including apigenin, biochanin A, luteolin, kaempferol, and quercetin. Docking validation produced an RMSD value of 0.39 Å, and quercetin exhibited the most favorable predicted binding energy among the evaluated compounds (−7.36 kcal mol⁻¹). These findings suggest that P. valida leaf extract possesses antibacterial potential against MRSA, with flavonoid-related metabolites as promising candidates for further investigation.
Keywords
Full Text:
PDFReferences
[1] A. S. Lee et al., “Methicillin-resistant Staphylococcus aureus,” Nat. Rev. Dis. Primers, vol. 4, Art. no. 18033, 2018. doi: 10.1038/nrdp.2018.33.
[2] N. A. Turner et al., “Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research,” Nat. Rev. Microbiol., vol. 17, no. 4, pp. 203–218, 2019. doi: 10.1038/s41579-018-0147-4.
[3] I. M. Gould et al., “New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance,” Int. J. Antimicrob. Agents, vol. 39, no. 2, pp. 96–104, 2012. doi: 10.1016/j.ijantimicag.2011.09.028.
[4] A. S. Abdel-Razek et al., “Microbial natural products in drug discovery,” Processes, vol. 8, no. 4, Art. no. 470, 2020. doi: 10.3390/pr8040470.
[5] A. G. Atanasov et al., “Natural products in drug discovery: Advances and opportunities,” Nat. Rev. Drug Discov., vol. 20, no. 3, pp. 200–216, 2021. doi: 10.1038/s41573-020-00114-z.
[6] B. Chopra and A. K. Dhingra, “Natural products: A lead for drug discovery and development,” Phytother. Res., vol. 35, no. 9, pp. 4660–4702, 2021. doi: 10.1002/ptr.7099.
[7] P. Angelini, “Plant-derived antimicrobials and their crucial role in combating antimicrobial resistance,” Antibiotics, vol. 13, no. 8, Art. no. 746, 2024. doi: 10.3390/antibiotics13080746.
[8] N. Jubair et al., “Review on the antibacterial mechanism of plant-derived compounds against multidrug-resistant bacteria (MDR),” Evid.-Based Complement. Altern. Med., vol. 2021, Art. no. 3663315, 2021. doi: 10.1155/2021/3663315.
[9] R. Upadhyay et al., “Role of secondary metabolites in plant defense mechanisms: A molecular and biotechnological insights,” Phytochem. Rev., vol. 24, pp. 953–983, 2025. doi: 10.1007/s11101-024-09976-2.
[10] A. Jupri et al., “Ethnobotany of food plants used by local communities at Joben Resort Mount Rinjani National Park, East Lombok,” J. Biol. Trop., vol. 22, no. 3, pp. 1025–1032, 2022. doi: 10.29303/jbt.v22i3.4094.
[11] Nelson et al., “Antioxidant activity of bioactive compounds in the ethyl acetate extract of putat leaves (Planchonia valida),” Chempublish J., vol. 6, no. 4, pp. 160–167, 2022. doi: 10.22437/chp.v6i4.41632.
[12] A. Bela et al., “In silico study of bioactive compounds of putat leaf extract (Planchonia valida) as anti-cancer against the VEGFR2 receptor,” J. Indones. Soc. Integr. Chem., vol. 16, no. 1, pp. 1–14, 2024. doi: 10.22437/jisic.v16i1.32049.
[13] F. Farid et al., “Isolation of bioactive compound in methanolic extract of putat leaves (Planchonia valida) as antioxidant,” Chempublish J., vol. 6, no. 4, pp. 132–140, 2022. doi: 10.22437/chp.v6i4.41634.
[14] T. T. Dewi et al., “Analisis LC-MS/MS senyawa metabolite ekstrak daun putat (Planchonia valida) dan prediksi potensinya sebagai kandidat obat antikanker,” J. Ilm. Ibnu Sina, vol. 9, no. 2, pp. 262–280, 2024. doi: 10.36387/jiis.v9i2.1629.
[15] G. Donadio et al., “Interactions with microbial proteins driving the antibacterial activity of flavonoids,” Pharmaceutics, vol. 13, no. 5, Art. no. 660, 2021. doi: 10.3390/pharmaceutics13050660.
[16] Y. Liu et al., “Flavonoids as promising natural compounds for combating bacterial infections,” Int. J. Mol. Sci., vol. 26, no. 6, Art. no. 2455, 2025. doi: 10.3390/ijms26062455.
[17] L. Song et al., “Antibacterial modes of herbal flavonoids combat resistant bacteria,” Front. Pharmacol., vol. 13, Art. no. 873374, 2022. doi: 10.3389/fphar.2022.873374.
[18] [18] Z. Zhang et al., “Research progress on the antibacterial activity of natural flavonoids,” Antibiotics, vol. 14, no. 4, Art. no. 334, 2025. doi: 10.3390/antibiotics14040334.
[19] C. V. Simoben et al., “Challenges in natural product-based drug discovery assisted with in silico-based methods,” RSC Adv., vol. 13, pp. 31578–31594, 2023. doi: 10.1039/D3RA06831E.
[20] M. Y. Ang and S. W. Choo, “The computational revolution in natural product research: A data-driven roadmap for next-generation drug development,” Biology, vol. 15, no. 8, Art. no. 632, 2026. doi: 10.3390/biology15080632.
[21] M. A. Ezeokonkwo and D. Kabir, “Applications of FTIR, GC-MS, and LC-MS in the identification of antimicrobial phytochemicals,” Arab. J. Chem. Environ. Res., vol. 13, no. 2, pp. 194–216, 2026.
[22] W. Y. Teoh et al., “LC-MS/MS and GC-MS analysis for the identification of bioactive metabolites responsible for the antioxidant and antibacterial activities of Lygodium microphyllum (Cav.) R. Br.,” Separations, vol. 10, no. 3, Art. no. 215, 2023. doi: 10.3390/separations10030215.
[23] K. S. Turabi et al., “Computational screening of phytochemicals for anti-bacterial drug discovery,” in Phytochemistry, Computational Tools and Databases in Drug Discovery. Amsterdam, The Netherlands: Elsevier, 2023, pp. 213–243. doi: 10.1016/B978-0-323-90593-0.00011-3.
[24] S. P. Gaudêncio et al., “Advanced methods for natural products discovery: Bioactivity screening, dereplication, metabolomics profiling, genomic sequencing, databases and informatic tools, and structure elucidation,” Mar. Drugs, vol. 21, no. 5, Art. no. 308, 2023. doi: 10.3390/md21050308.
[25] P. Sari et al., “Ethanolic extract gel of Planchonia valida leaves as an antibacterial agent against yersiniosis infection,” J. Kesehat. Lingkung., vol. 22, no. 1, pp. 69–78, 2025. doi: 10.31964/jkl.v22i1.906.
[26] Susilowati et al., “Synthesis and characterization chitosan film with silver nanoparticle addition as a multiresistant antibacterial material,” JKPK (J. Kim. dan Pendidik. Kim.), vol. 6, no. 3, pp. 371–383, 2021. doi: 10.20961/jkpk.v6i3.57101.
[27] R. Riga et al., “Isolation, structure elucidation and antibacterial activity of secondary metabolites from fungal Phyllosticta capitalensis,” Res. J. Pharm. Technol., vol. 17, no. 8, pp. 3663–3668, 2024. doi: 10.52711/0974-360X.2024.00571.
[28] S. Suryelita et al., “Phytochemical screening and biological activities of fungal Phyllosticta capitalensis derived from Andrographis paniculata,” Moroc. J. Chem., vol. 11, no. 2, pp. 553–565, 2023. doi: 10.48317/IMIST.PRSM/morjchem-v11i2.33657.
[29] R. Riga et al., “Endophytic fungus from Gynura japonica: Phytochemical screening, biological activities, and characterisation of its bioactive compound,” Nat. Prod. Res., vol. 39, no. 14, pp. 4117–4125, 2025. doi: 10.1080/14786419.2024.2332947.
[30] R. Sagia et al., “Phytochemical screening and antioxidant activity of fungus AS-3 isolated from the root of sambiloto,” J. Sumberd. Hayati, vol. 11, no. 2, pp. 49–54, 2025. doi: 10.29244/jsdh.11.2.49-54.
[31] E. Cortes, J. Mora, and E. Márquez, “Modelling the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of cannabinoids: A QSAR and docking study,” Crystals, vol. 10, no. 8, Art. no. 692, 2020. doi: 10.3390/cryst10080692.
[32] H. R. Anggraeni et al., “Identification of α-glucosidase inhibitory phytochemicals from Erythrina crista-galli using combined experimental and computational methods,” BMC Chem., vol. 20, no. 1, Art. no. 109, 2026. doi: 10.1186/s13065-026-01785-2.
[33] C. O. Manginstar et al., “Dual anti-inflammatory and antimicrobial effects of stingless bee propolis on second-degree burns,” Narra J., vol. 5, no. 1, Art. no. e2359, 2025. doi: 10.52225/narra.v5i1.2359.
[34] S. Vittorio et al., “Addressing docking pose selection with structure-based deep learning: Recent advances, challenges and opportunities,” Comput. Struct. Biotechnol. J., vol. 23, pp. 2141–2151, 2024. doi: 10.1016/j.csbj.2024.05.024.
[35] S. Abarna et al., “P-TSA-catalyzed green synthesis of new 1,4-dihydropyrimidine derivatives inhibitor for HER2 receptor as anti-cancer agents: Molecular docking, ADME-Tox analysis, DFT calculation & MD simulation,” Results Chem., vol. 20, Art. no. 103062, 2026. doi: 10.1016/j.rechem.2026.103062.
Refbacks
- There are currently no refbacks.
